Evaluate Safety/Tolerability in Portuguese Participants With RRMS Transitioning From Current Therapy

Clinical trial NCT03177083 · COMPLETED

Trial details

NCT number: NCT03177083
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2017-01-30
Primary completion: 2020-10-26
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.